Cargando…
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
Ewing sarcoma (EWS) is a malignant tumor arising in bone or soft tissue that occurs in adolescent and young adult patients as well as adults later in life. Although non-metastatic EWS is typically responsive to treatment when newly diagnosed, relapsed cases have an unmet need for which no standard t...
Autores principales: | Kim, Jin-Ah, Crawford, Kenneth A., Spada, Piero A., Martin, Leah R., Zhang, Jiaqi, Wong, Rain, Reid, Joel M., Stewart, Clinton F., Frank, Timothy M., Liu, Qianqian, Michalek, Joel E., Keller, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474113/ https://www.ncbi.nlm.nih.gov/pubmed/37658148 http://dx.doi.org/10.1038/s41598-023-40751-z |
Ejemplares similares
-
PEGylated talazoparib enhances therapeutic window of its combination with temozolomide in Ewing sarcoma
por: Del Pozo, Vanessa, et al.
Publicado: (2021) -
The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013) -
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma
por: Stolte, Björn, et al.
Publicado: (2018) -
Targeting the p53 Pathway in Ewing Sarcoma
por: Neilsen, Paul M., et al.
Publicado: (2011) -
Ewing Sarcoma: Rare Metastasis to the Pancreas
por: Guduguntla, Bhavna A., et al.
Publicado: (2022)